SELECTION AND CHARACTERIZATION OF L1210-SUBLINES RESISTANT TO TENIPOSIDE (VM-26)
- 1 January 1984
- journal article
- research article
- Vol. 44 (7) , 2981-2985
Abstract
Two spectra of L1210 sublines with gradations of resistance to teniposide (VM-26) were selected by stepwise exposure of cultures to increasing concentrations of the drug. Cultures representing the first spectrum were 20-1200 times more resistant to VM-26 than were cultures of parental cells. At 24 h after addition of 22 nM VM-26 to the medium, the growth of cultures of parental cells was inhibited by 50%. Increases in resistance to VM-26 among the sublines coincided with increases in population doubling times. When cells were transferred to drug-free medium, there was a sharp decrease in resistance over the first 10 days; the subsequent decline in resistance, over 2-4 mo., correlated with a decrease in population doubling times. The 2nd spectrum of resistant sublines arose from the first spectrum after the latter had been maintained for .apprx. 1 yr on various selective concentrations of VM-26. Resistance to VM-26 by this 2nd group of sublines was from 400 times to > 2000 times greater than that of the parental cell line. Doubling times for these resistant cell populations were similar to the normal rate of the parental cell line. Eight sublines were characterized by 2 chromosomes with homogeneously staining regions, while the remaining subline had a single chromosome with this anomaly. One of the regions appeared on a submetacentric chromosome in 7 of the 9 sublines, while the other was on an acrocentric chromosome. These observations indicate that a longer doubling time facilitated selection of increasingly resistant sublines but was not essential for the resistance of sublines in the 2nd spectrum.This publication has 13 references indexed in Scilit:
- Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicityCancer, 1981
- RESPONSE OF L1210 LEUKEMIA TO TREATMENT WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA PLUS 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-O-2-THENYLIDENE-BETA-D-GLUCOPYRANOSIDE)1981
- VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemiaCancer, 1980
- SEDIMENTATION OF DNA FROM L1210 CELLS AFTER TREATMENT WITH 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-O-2-THENYLIDENE-BETA-D-GLUCOPYRANOSIDE) OR 1-BETA-D-ARABINOFURANOSYLCYTOSINE OR BOTH DRUGS1980
- A quantitative microdensitometric and autoradiographic study of the effect of 4?-demethyl-epipodophyllotoxin-?-D-thenylidene glucoside (VM-26) on the cell cycle of cultured fibroblastsJournal of Molecular Histology, 1979
- Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes.Proceedings of the National Academy of Sciences, 1979
- Correlation of dihydrofolate reductase elevation with gene amplification in a homogeneously staining chromosomal region in L5178Y cells.The Journal of cell biology, 1979
- COMPARATIVE-STUDY OF EARLY EFFECTS OF EPIPODOPHYLLOTOXIN DERIVATIVES AND OTHER CYTOSTATIC AGENTS ON MASTOCYTOMA CULTURES1977
- VM26-INDUCED CHANGES IN HEPATIC INTERMEDIARY METABOLISM OF MICE1977
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976